Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects

Psychological Medicine

Volumn 41, Issue 2, 2011, Pages 419-429

  Burke, S M ^a,b   Van De Giessen, E ^b   De Win, M ^b   Schilt, T ^c   Van Herk, M ^d   Van Den Brink, W ^c   Booij, J ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Dopamine transporter; healthy controls; neuropsychological functioning; serotonin transporter; SPECT

Indexed keywords

DOPAMINE TRANSPORTER; SEROTONIN TRANSPORTER;

ADOLESCENT; ADULT; AFFECT; ARTICLE; BRAIN; COGNITION; EVALUATION; FEMALE; HUMAN; IMPULSIVENESS; MALE; METABOLISM; NETHERLANDS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONALITY; PHYSIOLOGY; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; AFFECT; BRAIN; COGNITION; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MAGNETIC RESONANCE IMAGING; MALE; NETHERLANDS; NEUROPSYCHOLOGICAL TESTS; PERSONALITY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YOUNG ADULT;

EID: 79952818431     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291710000486     Document Type: Article

References (69)

1. 99mTc] TRODAT-1 and single-photon emission tomography. European Journal of Nuclear Medicine 27, 1714-1718.
2. Aouizerate B, Guehl D, Cuny E, Rougier A, Burbaud P, Tignol J, Bioulac B (2005). Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder. Neuropsychiatric Disease and Treatment 1, 231-243.
3. Bechara A, Damasio AR, Damasio H, Anderson SW (1994). Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 50, 7-15.
4. Bechara A, Damasio H, Damasio AR (2000). Emotion, decision making and the orbitofrontal cortex. Cerebral Cortex 10, 295-307. (Pubitemid 30159296)
5. Bechara A, Damasio H, Damasio AR, Lee GP (1999). Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making. Journal of Neuroscience 19, 5473-5481. (Pubitemid 29300212)
6. Beck AT, Steer RA, Brown GK (2002). Beck Depression Inventory II. In Manual of the Dutch Version of the BDI [in Dutch] (ed. AJW. van der Does). The Psychological Corporation/Swets Test Publishers: San Antonio, TX/Lisse, The Netherlands.
7. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961). An inventory for measuring depression. Archives of General Psychiatry 4, 561-571.
8. Benton AL, Varney NR, Hamsher KD (1987). Visuospatial judgment: a clinical test. Archives of Neurology 35, 364-367.
9. Borg J, Henningsson S, Saijo T, Inoue M, Bah J, Westberg L, Lundberg J, Jovanovic H, Andree B, Nordstrom AL, Halldin C, Eriksson E, Farde L (2009). Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humans. International Journal of Neuropsychopharmacology 12, 783-792.
10. Cloninger CR (1987). A systematic method for clinical description and classification of personality variants: a proposal. Archives of General Psychiatry 44, 573-588. (Pubitemid 17082099)
11. 123I]b-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. Neuropsychopharmacology 30, 996-1005. (Pubitemid 40570914)
12. De Win MML, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, den Heeten GJ, van den Brink W (2008). Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain 131, 2936-2945.
13. De Win MML, Jager G, Vervaeke HKE, Schilt T, Reneman L, Booij J, Verhulst FC, den Heeten GJ, Ramsey NF, Korf DJ, van den Brink W (2005b). The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. International Journal of Methods in Psychiatric Research 14, 167-185. (Pubitemid 43013585)
14. De Win MML, Reneman L, Jager G, Vlieger EJ, Olabarriaga SD, Lavini C, Bisschops I, Majoie CBLM, Booij J, den Heeten GJ, van den Brink W (2007). A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology 32, 458-470. (Pubitemid 46106952)
15. Edmonds CJ, Isaacs EB, Visscher PM, Rogers M, Lanigan J, Singhal A, Lucas A, Gringras P, Denton J, Deary IJ (2008). Inspection time and cognitive abilities in twins aged 7 to 17 years: age-related changes, heritability and genetic covariance. Intelligence 36, 210-255.
16. Feij JA, Van Zuilen RW, Gazendam A (1982). The development of a Dutch questionnaire for sensation seeking: the sensation seeking scale [in Dutch]. Gedrag: Tijdschrift voor Psychologie 10, 364-383.
17. Friedman NP, Miyake A, Young SE, De Fries JC, Corley RP, Hewitt JK (2008). Individual differences in executive functions are almost entirely genetic in origin. Journal of Experimental Psychology: General 137, 201-225.
18. Gottesman II, Gould TD (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry 160, 636-645. (Pubitemid 41079594)
19. Graham FK, Kendall BS (1960). Memory-For-Designs Test: revised general manual. Perceptual and Motor Skills 11, 147-188.
20. Gronwall DMA (1977). Paced Auditory Serial-Addition Task: a measure of recovery from concussion. Perceptual and Motor Skills 44, 367-373.
21. Gudelsky GA, Yamamoto BK (2008). Actions of 3,4- methylenedioxymethamphetamine(MDMA)oncerebral dopaminergic, serotonergic and cholinergic neurons. Pharmacology, Biochemistry, and Behavior 90, 198-207. (Pubitemid 351787346)
22. Hariri AR, Holmes A (2006). Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends in Cognitive Sciences 10, 182-191.
23. Hosmer L, Lemeshow S (2001). Applied Logistic Regression : Textbook and Solutions Manual. John Wiley & Sons: New York.
24. Howes OD, Kapur S (2009). The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophrenia Bulletin 35, 549-562.
25. Ichimiya T, Suhara T, Sudo Y, Okubo Y, Nakayama K, Nankai M, Inoue M, Yasuno F, Takano A, Maeda J, Shibuya H (2002). Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652. Biological Psychiatry 51, 715-722. (Pubitemid 34450807)
26. Innis RB, Cunningham VJ, Delforge J, Fujita M, Giedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Lida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007). Consensus nomenclature for in vivo imaging of reversibly binding radioligands. Journal of Cerebral Blood Flow and Metabolism 27, 1533-1539. (Pubitemid 47301451)
27. 123I] nor-b-CIT SPECT imaging. Psychiatry Research: Neuroimaging 154, 125-131. (Pubitemid 46275440)
28. Johanson CE, Frey KA, Lundahl LH, Keenan P, Lockhart N, Roll J, Galloway GP, Koeppe RA, Kilbourn MR, Robbins T, Schuster CR (2006). Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology (Berlin) 185, 327-338.
29. Kalbitzer J, Frokjaer VG, Erritzoe D, Svarer C, Cumming P, Nielsen FA, Hashemi SH, Baare WF, Madsen J, Hasselbalch SG, Kringelbach ML, Mortensen EL, Knudsen GM (2009). The personality trait openness is related to cerebral 5-HTT levels. NeuroImage 45, 280-285.
30. 123I]ADAM and SPECT in patients with borderline personality disorder and healthy control subjects. Journal of Psychiatry and Neuroscience 32, 234-240. (Pubitemid 47057456)
31. 123I]beta-CIT binding to dopamine transporters in healthy human subjects. Journal of Cerebral Blood Flow and Metabolism 14, 982-994.
32. Lehto SM, Tolmunen T, Joensuu M, Saarinen PI, Valkonen-Korhonen M, Vanninen R, Ahola P, Tiihonen J, Kuikka J, Lehtonen J (2008a). Changes in midbrain serotonin transporter availability in atypically depressed subjects after one year of psychotherapy. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32, 229-237.
33. Lehto SM, Tolmunen T, Kuikka J, Valkonen-Korhonen M, Joensuu M, Saarinen PI, Vanninen R, Ahola P, Tiihonen J, Lehtonen J (2008b). Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study. Neuroscience Letters 441, 291-295.
34. Lindström M, Ryding E, Bosson P, Ahnlide JA, Rosén I, Träskman-Bendz L (2004). Impulsivity related to brain serotonin transporter binding capacity in suicide attempters. European Neuropsychopharmacology 14, 295-300. (Pubitemid 38649086)
35. Maron E, Kuikka JT, Shlik J, Vasar V, Vanninen E, Tiihonen J (2004). Reduced brain serotonin transporter binding in patients with panic disorder. Psychiatry Research 132, 173-181. (Pubitemid 39643014)
36. McCann UD, Szabo Z, Vranesic M, Palermo M, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA (2008). Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (¡)3,4- methylenedioxymethamphetamine ('ecstasy') users: relationship to cognitive performance. Psychopharmacology 200, 439-450.
37. Meneses A (1999). 5-HT system and cognition. Neuroscience and Biobehavioral Reviews 23, 1111-1125.
38. Meyer JH, Houle S, Sagrati S, Carella A, Hussey DF, Ginovart N, Goulding V, Kennedy J, Wilson AA (2004). Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Archives of General Psychiatry 61, 1271-1279. (Pubitemid 39602843)
39. Mozley LH, Gur RC, Mozley PD, Gur RE (2001). Striatal dopamine transporters and cognitive functioning in healthy men and women. American Journal of Psychiatry 158, 1492-1499. (Pubitemid 32847251)
40. Nelson HE, O'Connell A (1978). Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex 14, 234-244. (Pubitemid 8386900)
41. Newberg AB, Amsterdam JD, Wintering N, Ploessl K, Swanson RL, Shults J, Alavi A (2005). I-123-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. Journal of Nuclear Medicine 46, 973-977. (Pubitemid 43733512)
42. Oades RD (2008). Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD). Progress in Brain Research 172, 543-565.
43. Parsey RV, Hastings RS, Oquendo MA, Huang YY, Simpson N, Arcement J, Huang Y, Ogden RT, Van Heertum RL, Arango V, Mann JJ (2006). Lower serotonin transporter binding potential in the human brain during major depressive episodes. American Journal of Psychiatry 163, 52-58. (Pubitemid 43050103)
44. Pattij T, Vanderschuren LJMJ (2008). The neuropharmacology of impulsive behaviour. Trends in Pharmacological Sciences 29, 192-199.
45. Patton JH, Stanford MS, Barratt ES (1995). Factor structure of the Barratt Impulsiveness Scale. Journal of Clinical Psychology 51, 768-774. (Pubitemid 26021724)
46. Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Rieder N, Angelberger P, Brucke T (2000). Imaging serotonin and dopamine transporters with I-123-beta-CIT SPECT: binding kinetics and effects of normal aging. Journal of Nuclear Medicine 41, 36-44. (Pubitemid 30046682)
47. Reneman L, Booij J, de Bruin K, Reitsma JR, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W (2001a). Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 358, 1864-1869. (Pubitemid 34008653)
48. Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten G, Booij J (2001b). Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy'). Archives of General Psychiatry 58, 901-906. (Pubitemid 32937910)
49. Rey A (1964). The Clinical Examination in Psychology [in French]. Presses Universitaires de France: Paris, France.
50. Robbins TW, Roberts AC (2007). Differential regulation of fronto-executive function by the monoamines and acetylcholine. Cerebral Cortex 17, I151-I160.
51. Roiser JP, Rogers RD, Cook LJ, Sahakian BJ (2006). The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls. Psychopharmacology 188, 213-227. (Pubitemid 44371159)
52. Ryding E, Ahnlide JA, Lindström M, Rosén I, Träskman-Bendz L (2006). Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy. Psychiatry Research: Neuroimaging 148, 195-203. (Pubitemid 44750588)
53. Schilt T, de Win MML, Koeter M, Jager G, Korf DJ, van den Brink W, Schmand B (2007). Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Archives of General Psychiatry 64, 728-736. (Pubitemid 46878673)
54. Schmand BA, Bakker D, Saan RJ, Louman J (1991). The Dutch reading test for adults: a measure of premorbid intelligence level [in Dutch]. Tijdschrift voor Gerontologie en Geriatrie 22, 15-19.
55. Seibyl JP, Laruelle M, van Dyck CH, Wallace E, Baldwin RM, Zoghbi S, Zea-Ponce Y, Neumeyer JL, Charney DS, Hoffer PB, Innis RB (1996). Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters. Journal of Nuclear Medicine 37, 222-228. (Pubitemid 26150892)
56. Shepard RN, Metzler J (1971). Mental rotation of three-dimensional objects. Science 171, 701-703.
57. Stahl SM (2000). Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 2nd edn. Cambridge University Press: New York.
58. Suhara T, Yasuno F, Sudo Y, Yamamoto M, Inoue M, Okubo Y, Suzuki K (2001). Dopamine D2 receptors in the insular cortex and the personality trait of novelty seeking. NeuroImage 13, 891-895. (Pubitemid 32848333)
59. Takano A, Arakawa R, Hayashi M, Takahashi H, Ito H, Suhara T (2007). Relationship between neuroticism personality trait and serotonin transporter binding. Biological Psychiatry 62, 588-592. (Pubitemid 47314374)
60. Tiihonen J, Kuikka JT, Bergstrom KA, Karhu J, Viinamaki H, Lehtonen J, Hallikainen T, Yang JW, Hakola P (1997). Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour. European Journal of Nuclear Medicine 24, 1253-1260. (Pubitemid 27477618)
61. Tsai HC, Yeh TL, Hsieh MH, Lee IH, Chen KC, Chen PS, Yang YK, Yao WJ (2009). Association between serotonin transporter availability and overall rating scores of quality of life in healthy volunteers. Progress in Neuro-Psychopharmacology and Biological Psychiatry 33, 711-714.
62. Van den Burg W, Saan RJ, Deelman BG (1985). 15-Woordentest: Provisional Manual. University Hospital : Groningen, The Netherlands.
63. Van Der Wee NJ, van Veen JF, Stevens H, van Vliet IM, van Rijk PP, Westenberg HG (2008). Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 123I-beta-(4-iodophenyl)-tropane SPECT. Journal of Nuclear Medicine 49, 757-763. (Pubitemid 351717541)
64. Van Dyck CH, Malison RT, Seibyl JP, Laruelle M, Klumpp H, Zoghbi SS, Baldwin RM, Innis RB (2000). Age-related decline in central serotonin transporter availability with [I-123]beta-CIT SPECT. Neurobiology of Aging 21, 497-501. (Pubitemid 30621487)
65. Van Herk M, de Jaeger K, de Munck J, Hoogeman M, Meinders JPL, Zijp L (2000). A delineation system for N modalities - software aspects (Extended Abstract). In Proceedings XIII International Conference on the Use of Computers in Radiation Therapy (XII ICCR) (ed. W. Schlegel and T. Bortfelt), pp. 73-75. Springer-Verlag: Heidelberg, Germany.
66. Wechsler D (1981). WAIS-R Manual. The Psychological Corporation: San Antonio, TX.
67. Zhu J, Reith ME (2008). Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse. CNS and Neurological Disorders Drug Targets 7, 393-409.
68. Zuckerman M, Kuhlman DM (2000). Personality and risk-taking: common biosocial factors. Journal of Personality 68, 999-1029.
69. Zuckerman M, Link K (1968). Construct validity for the sensation-seeking scale. Journal of Consulting and Clinical Psychology 32, 420-426.